Max Robotics — Global Service Robot Directory + US Certification

About

Enliang Li is a pioneering hepatobiliary surgeon whose research focuses on advancing minimally invasive surgical techniques for complex liver and gallbladder cancers. His major contributions center on demonstrating the feasibility and safety of robotic surgery for challenging oncologic resections, particularly through comparative studies against traditional open approaches. In his landmark 2022 study on robotic versus open extended cholecystectomy for T1a–T3 gallbladder cancer (9 citations), Li provided critical evidence that robotic approaches can achieve comparable oncologic outcomes with potentially reduced morbidity. His 2023 work on robotic hepatectomy combined with enhanced recovery after surgery (ERAS) protocols (7 citations) showed that integrating robotic technology with perioperative optimization can improve outcomes while potentially offsetting cost concerns. Additionally, his application of the IWATE criteria to compare surgical approaches for hepatectomy (5 citations) has helped standardize patient selection for minimally invasive liver surgery. Li’s research is particularly notable for its practical clinical focus, directly addressing surgeons’ concerns about adopting robotic techniques in complex hepatobiliary cases. His work continues to shape evidence-based guidelines for robotic liver and gallbladder surgery, making him a respected voice in the field of surgical oncology.